REG - Experian plc - Additional Listing

RNS Number : 8345X Experian plc 03 September 2025 Experian plcAdditional Listing3 September 2025 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market that application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 48,000 ordinary shares of US 10 cents each to be admitted to the Official List.The shares are expected to be admitted to the Official List and to trading on the London Stock Exchange on 5 September 2025.These shares are being reserved under a block listing and will be issued as a result of the award of shares pursuant to the Experian International Sharesave Plan.When issued, these shares will rank pari passu with the existing ordinary shares.Contact:ExperianClaire MurphyDeputy Company Secretary+353 (0) 87 118 4397About ExperianExperian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ALSLJMLTMTMMMBA